Showing 1 - 10 of 18
Persistent link: https://www.econbiz.de/10011334524
In the last decades, technologies became more complex which increased the degree of uncertainty in R&D. To overcome the uncertainty, firms frequently engage in R&D collaborations, e.g., Research Joint Ventures (RJVs), and licensing agreements. While RJVs are well explored in the literature, very...
Persistent link: https://www.econbiz.de/10010223406
Persistent link: https://www.econbiz.de/10001536728
Persistent link: https://www.econbiz.de/10003492476
Persistent link: https://www.econbiz.de/10003567125
Our study puts special attention to the fact that R&D cooperations in the pharmaceutical industry are formed at different stages throughout the drug development process. We study if the timing to engage in R&D cooperations in the pharmaceutical industry has different impacts on the technology...
Persistent link: https://www.econbiz.de/10010229875
Persistent link: https://www.econbiz.de/10001966320
Persistent link: https://www.econbiz.de/10001511174
Persistent link: https://www.econbiz.de/10001374285
Merger control authorities may approve a merger based on a so-called “efficiency defence”. An important aspect in clearing mergers is that the efficiencies need to be merger-specific. Joint ventures, and in particular research joint ventures (RJVs), may achieve comparable efficiencies...
Persistent link: https://www.econbiz.de/10012951289